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Abstract 
OBJECTIVES: 
The aim of this work was to study the interaction between genetic polymorphisms 
(single-nucleotide polymorphisms, SNPs) of pro- and anti-inflammatory cytokines and 
fat intake on the risk of developing Crohn's disease (CD) or modifying disease activity. 
METHODS: 
Seven SNPs in interleukin 1 (IL1), tumor necrosis factor alpha (TNFα), lymphotoxin 
alpha (LTα), and IL6 genes were analyzed in 116 controls and 99 patients with CD. The 
type of fat intake was evaluated, and the interaction between SNPs and dietary fat in 
modulating disease activity was analyzed. 
RESULTS: 
Individuals who were homozygous for the IL6−174G/C polymorphism had a six-fold 
higher risk for CD (odds ratio (OR)=6.1; 95% confidence interval (95% CI)=1.9–19.4), 
whereas the TT genotype on the TNFα−857C/T polymorphism was associated with 
more active disease (OR=10.4; 95% CI=1.1–94.1). A high intake of total, saturated, and 
monounsaturated fats, as well as a higher ratio of n-6/n-3 polyunsaturated fatty acid 
(PUFA), was associated with a more active phenotype (P<0.05). Furthermore, there 
was an interaction between dietary fat intake and SNPs, with a high intake of saturated 
and monounsaturated fats being associated with active disease, mainly in patients 
carrying the variant alleles of the 857 TNFα polymorphism (OR=6.0, 95% CI=1.4–26.2; 
OR=5.17; 95% CI=1.4–19.2, respectively) and the 174 IL6 polymorphism (OR=2.95; 95% 
CI=1.0–9.1; OR=3.21; 95% CI=1.0–10.4, respectively). Finally, low intake of n-3 PUFA 
and high n-6/n-3 PUFA ratio in patients with the TNFα 857 polymorphism were 
associated with higher disease activity (OR=3.6; 95% CI=1.0–13.0; OR=5.92; 95% 
CI=1.3–26.5, respectively). 
CONCLUSIONS: 
These results show that different types of fat may interact with cytokine genotype, 
modulating disease activity. 
 
